For: | Abdel-Salam OM. Drug therapy for Parkinson’s disease: An update. World J Pharmacol 2015; 4(1): 117-143 [DOI: 10.5497/wjp.v4.i1.117] |
---|---|
URL: | https://www.wjgnet.com/2220-3192/full/v4/i1/117.htm |
Number | Citing Articles |
1 |
Omar M.E. Abdel-Salam, Eman R. Youness, Nadia A. Ahmed, Sayed A. El-Toumy, Ahmed M.A. Souleman, Nermeen Shaffie, Dalia M. Abouelfadl. Bougainvillea spectabilis flowers extract protects against the rotenone-induced toxicity. Asian Pacific Journal of Tropical Medicine 2017; 10(5): 478 doi: 10.1016/j.apjtm.2017.05.013
|
2 |
Xi Chen, Yuanyuan Wang, Haifeng Wu, Cheng Cheng, Weidong Le. Research advances on L-DOPA-induced dyskinesia: from animal models to human disease. Neurological Sciences 2020; 41(8): 2055 doi: 10.1007/s10072-020-04333-5
|
3 |
Soha Mohamed Hamdy, Nada Ahmed Elsayed, Eman R. Youness, Heba Mohamed Rabie Elesh, Omar M. E. Abdel-Salam. Effect of cytidine-5′-diphosphocholine alone, caffeine or their combination on oxidative stress and inflammatory response in an experimentally-induced Parkinson’s disease. Journal of Complementary and Integrative Medicine 2025; doi: 10.1515/jcim-2024-0447
|
4 |
Miguel Reina, Christian A. Celaya, Jesús Muñiz. Cn and Cn‐1B Fullerenes as Potential Nanovehicles for Piribedil Neuroprotective Drug (n=20, 36 and 60). ChemistrySelect 2019; 4(47): 13916 doi: 10.1002/slct.201904211
|